Notoginseny Cream in the Treatment of Phlebitis

Journal of Infusion Nursing

Volumn 26, Issue 1, 2003, Pages 49-54

  Gouping, Zhang ^a,b   Wan Er, Tan ^a   Xue Ling, Weng ^a   Min Qian, Xian ^a   Kun, Fang ^b   Turale, Sue ^c   Fisher, John W ^c  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF BALLARAT   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; HIRUDOID; INFUSION FLUID; NOTOGINSEY CREAM; UNCLASSIFIED DRUG; GINSENOSIDE; HEPARINOID; HERBACEOUS AGENT; NOTOGINSENOSIDE R1;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINESE MEDICINE; CLINICAL FEATURE; CONTROLLED STUDY; CREAM; DRUG EFFECT; DRUG EFFICACY; EDEMA; ERYTHEMA; FEMALE; HUMAN; INFUSION; MAJOR CLINICAL STUDY; MALE; PAIN; PHLEBITIS; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; NURSING ASSESSMENT; OINTMENT; PHYTOTHERAPY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RHUBARB; SAFFLOWER; TIME; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARTHAMUS TINCTORIUS; CHILD; CHILD, PRESCHOOL; DRUGS, CHINESE HERBAL; FEMALE; GINSENOSIDES; HEPARINOIDS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NURSING ASSESSMENT; OINTMENTS; PHLEBITIS; PHYTOTHERAPY; RHEUM; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037267611     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200301000-00007     Document Type: Article

References (14)

1. Wright A. Reducing infusion failure. A pharmacological approach: a review. J Intraven Nurs. 1996;19:89-97.
2. Infusion Nurses Society. Infusion nursing standards of practice. 2000;23(6S).
3. Jackson A. Infection control. A battle in vein: infusion phlebitis. Nursing Times. 1998;94(4):68, 71.
4. Campbell L. Clinical. IV-related phlebitis: complications and length of hospital stay. Parts 1 and 2. Br J Nurs. 1998;7(21 1304-1312;7(22):1364-1370.
5. Campbell L. Clinical. IV-related phlebitis: complications and length of hospital stay. Parts 1 and 2. Br J Nurs. 1998;7(21 1304-1312;7(22):1364-1370.
6. Hadaway LC. IV infiltration: not just a peripheral problem. Nursing2002. 2002;32(8):36-42.
7. Hadaway LC. IV infiltration: not just a peripheral problem. Nursing1999. 1999;29(9):41-47.
8. British National Formulary topical circulatory preparations. Available at: http://bnf.vhn.net/bnf/documents/bnf.2523.html. Accessed September 2002.
9. Woodhouse CR. Movelat in the prevention of infusion thrombophlebitis. Br Med J. 1979;1:454-455.
10. Tobin CR. The Teflon intravenous catheter: incidence of phlebitis and duration of catheter life in the neonatal patient. J Obstet Gynecol Neonat Nurs. 1988.
11. Tully JL, Friedland GH, Baldini LM, et al. Complications of intravenous therapy with steel needles and Teflon catheters: a comparative study. Am J Med. 1981;70(3):702-706.
12. Tager IB, Ginsberg MB, Ellis SE, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol. 1988;118:839-851.
13. Kuwahara T, Asanami S, Kawauchi Y, et al. Experimental infusion phlebitis: tolerance pH of peripheral vein. J Toxicol Sci. 1999;24(2):113-121.
14. Xu Ly. Reaction of infusion and therapy. J Rural Doctor. 1994;11:12-14.